News Agency
The Times

BioDlink Congratulates Junshi Biosciences on IND Approval of JS212, a Bispecific ADC Therapeutic Candidate

  • Written by PR Newswire
BioDlink Congratulates Junshi Biosciences on IND Approval of JS212, a Bispecific ADC Therapeutic Candidate
  • BioDlink congratulates Junshi Biosciences on receiving IND approval from China'sNMPA for JS212, the company's first bispecific ADC.
  • JS212 combines dual-targeting antibody technology with a cytotoxic payload, representing a next-generation therapeutic.
  • BioDlink provided end-to-end development and manufacturing support, showcasing its industry-leading...

Read more: BioDlink Congratulates Junshi Biosciences on IND Approval of JS212, a Bispecific ADC Therapeutic...

Selecting Steel Plate for Industrial and Fabrication Projects

Start with the job requirements A successful fabrication project starts with material that suits the work it must perform. Choosing steel plate involves more than selecting a thickness from a stock list. Designers and procurement teams need to consider the load... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion